Home › Funds › Legacy Wealth Asset Management, LLC › IBD

Legacy Wealth Asset Management, LLC position in IBD

NORTHERN LTS FD TR IV

Legacy Wealth Asset Management, LLC reported holding 256,141 shares of IBD (NORTHERN LTS FD TR IV) in its Q3 2026 13F filing — a position valued at US$5.9M, representing 1.29% of its reported portfolio and ranking #11 among its reported holdings. Legacy Wealth Asset Management, LLC has disclosed IBD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)256.14K sh
Reported value held$5.89M
Portfolio Weight1.29%
First reportedQ3 2023
Last changeAdd
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How Legacy Wealth Asset Management, LLC's IBD position evolved

Legacy Wealth Asset Management, LLC first disclosed a stake in IBD in Q3 2023 at 126,911 shares (US$2.9M). The position peaked in Q3 2026 at 256,141 shares, worth US$5.9M. Across 13 filings, Legacy Wealth Asset Management, LLC increased the stake 10 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 256,141 shares valued at US$5.9M — an increase of 71,372 shares quarter over quarter.. Notable position changes include a 39% increase in Q3 2026 (shares rose 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 126.91K $2.87M New
Q4 2023 123.91K $2.92M Reduce
Q1 2024 128.42K $3.02M Add
Q2 2024 139.63K $3.26M Add
Q3 2024 140.79K $3.39M Add
Q4 2024 140.73K $3.30M Hold
Q1 2025 142.71K $3.39M Add
Q2 2025 147.19K $3.53M Add
Q3 2025 151.63K $3.66M Add
Q4 2025 159.63K $3.86M Add
Q1 2026 170.55K $4.07M Add
Q2 2026 184.77K $4.39M Add
Q3 2026 256.14K $5.89M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IBD and 13F data

IBD (NORTHERN LTS FD TR IV) is a company whose sector is not yet classified in our data. 30 other funds we track also report a position in IBD — the largest reported positions include Inspire Advisors, LLC (US$97.5M), Faithward Advisors, LLC (US$40.8M), CREATIVE FINANCIAL DESIGNS INC /ADV (US$23.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IBD

All IBD fund holders →

FAQ

How long has Legacy Wealth Asset Management, LLC held IBD?

Legacy Wealth Asset Management, LLC has disclosed IBD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Legacy Wealth Asset Management, LLC's current position in IBD?

As of Q3 2026, Legacy Wealth Asset Management, LLC holds 256.14K shares of IBD (NORTHERN LTS FD TR IV), valued at $5.89M, representing 1.29% of its reported portfolio and ranking #11.

Has Legacy Wealth Asset Management, LLC been buying or selling IBD?

In the latest 13F filing (Q3 2026), Legacy Wealth Asset Management, LLC increased its position in IBD. The position peaked in Q3 2026 at 256.14K shares.

Which other funds hold IBD?

Other major institutional holders of IBD include Inspire Advisors, LLC, Faithward Advisors, LLC, CREATIVE FINANCIAL DESIGNS INC /ADV, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.